Evidence map›Paper›PMID 40347348›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2025

Reversible Inhibition of Cysteine Proteases Using S-Methyl Methanethiosulfonate.

Srđan Marković, Natalija Polović

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Srđan Marković
Natalija PolovićDepartment of Biochemistry, University of Belgrade - Faculty of Chemistry, Belgrade, Serbia. polovicn@chem.bg.ac.rs.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cysteine proteases find applications in diverse fields, but their susceptibility to autolysis poses storage challenges. Unlike irreversible inhibitors, S-methyl methanethiosulfonate (MMTS) enables enzyme reactivation, offering an ideal solution for preventing autolysis during storage and allowing subsequent protein activation when required. Here, we describe effective methods for inhibiting and reactivating papain, providing valuable insights for enhancing the storage and usability of cysteine proteases in various scientific, medical, and industrial applications.

Indexed as

Cysteine ProteasesCysteine Proteinase InhibitorsMethyl MethanesulfonatePapainEnzyme ActivationCysteine ProteasesCysteine Proteinase InhibitorsMethyl MethanesulfonatePapainCysteine proteaseMMTSPapainReversible inhibitionS-methyl methanethiosulfonate

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.